Latest News

Authors: Heinz Ludwig, Pieter Sonneveld, Faith Davies, Joan Bladé, Mario Boccadoro, Michele Cavo, Gareth Morgan, Javier de la Rubia, Michel Delforge, Meletios Dimopoulos, Hermann Einsele, Thierry Facon, Hartmut Goldschmidt, Philippe Moreau, Hareth Nahi, Torben Plesner, Jesús San-Miguel, Roman Hajek, Pia Sondergeld and Antonio Palumbo. The treatment of multiple myeloma has undergone significant changes and has…

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled eff ectiveness trial for the SMaRT (Symptom Management Research Trials) Oncology-2 Michael Sharpe, Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Charlie Gourley, Lucy Wall, David Weller, Gordon Murray,

Value in Health, Volume 17, Issue 4, Pages 471-475, June 2014 Authors:C. Daniel Mullins, PhD; Joseph Vandigo, MBA; Zhiyuan Zheng, PhD; Paul Wicks, PhD To view the article, please click here.

EUROCARE 5 results where presented at the European Parliament on 5 December 2013. Some of the conclusions were: • The number of adults survive at least 5 years after diagnosis has increased steadily over time in all regions of Europe from 1999 to 2007 , BUT STILL cancer survival varies widely between European countries.

Madrid, Saturday 13 April 2013 (9:00am – 4:30pm)   After the success of MPe’s I Masterclass that took place in Edinburgh last year, the second one will follow this spring focusing on myeloma genetics and the role of bio banks. The issue will be presented and discussed from a medical point of view, but also…